Procter & Gamble
Executive Summary
Agreement with aging disease R&D firm Senetek gives P&G exclusive worldwide right to market products using Senetek's Factor X technology. The company reports that early results indicate that Factor x could be useful in treating some skin conditions. Terms of the deal were not disclose.